New inhibitors of tyrosyl-DNA phosphodiesterase I (Tdp 1) combining 7-hydroxycoumarin and monoterpenoid moieties

Bioorg Med Chem. 2016 Nov 1;24(21):5573-5581. doi: 10.1016/j.bmc.2016.09.016. Epub 2016 Sep 13.

Abstract

A number of derivatives of 7-hydroxycoumarins containing aromatic or monoterpene substituents at hydroxy-group were synthesized based on a hit compound from a virtual screen. The ability of these compounds to inhibit tyrosyl-DNA phosphodiesterase I (Tdp 1), important target for anti-cancer therapy, was studied for the first time. It was found that the 7-hydroxycoumarin derivatives with monoterpene pinene moiety are effective inhibitors of Tdp 1 with the most active derivative (+)-25c with IC50 value of 0.675μM. This compound has low cytotoxicity (CC50>100μM) when tested against human cancer cells which is crucial for presupposed application in combination with clinically established anticancer drugs. The ability of the new compounds to enhance the cytotoxicity of camptothecin, an established topoisomerase 1 poison, was demonstrated.

Keywords: Coumarin; Molecular modeling; Monoterpene; Tyrosyl-DNA Phosphodiesterase I inhibitor.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Dose-Response Relationship, Drug
  • Humans
  • Molecular Docking Simulation
  • Molecular Structure
  • Monoterpenes / chemistry
  • Monoterpenes / pharmacology*
  • Phosphodiesterase Inhibitors / chemical synthesis
  • Phosphodiesterase Inhibitors / chemistry
  • Phosphodiesterase Inhibitors / pharmacology*
  • Phosphoric Diester Hydrolases / metabolism*
  • Structure-Activity Relationship
  • Umbelliferones / chemistry
  • Umbelliferones / pharmacology*

Substances

  • Monoterpenes
  • Phosphodiesterase Inhibitors
  • Umbelliferones
  • 7-hydroxycoumarin
  • Phosphoric Diester Hydrolases
  • TDP1 protein, human